| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $15,475,014 ) (Continued on the next page) |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 002 | 23 | NIH | 7/30/2025 | $175,000 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R00HD107262 | Regulation of Invasive Trophoblast Cell Lineage Development | 000 | 5 | NIH | 8/5/2025 | $249,000 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01CA279065 | Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer | 004 | 4 | NIH | 5/23/2025 | $53,385 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01CA279065 | Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer | 003 | 4 | NIH | 4/7/2025 | $480,482 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01CA290670 | DNA Repair Deficiencies in Infertile Men and Cancer Risk | 002 | 3 | NIH | 8/6/2025 | $569,733 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R21AI185859 | Development of mosaic enterovirus mRNA vaccine to prevent hand, foot and mouth disease | 000 | 1 | NIH | 6/26/2025 | $433,175 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01DK139363 | Addressing social determinants of health in child obesity treatment using community health workers: the role of parental bandwidth in treatment effectiveness - feasibility study for full - scale RCT | 000 | 2 | NIH | 2/17/2025 | $236,877 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23HL153895 | The Impact of Public Reporting on Procedural Outcomes Following Congenital Heart Surgery | 000 | 4 | NIH | 12/9/2024 | $166,869 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | H9E53187 | Transition for Youth with Autism and/or Epilepsy Demonstration Projects | 00 | 2 | HRSA | 7/23/2025 | $450,000 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD115359 | 5-base HiFi sequencing to advance the understanding of genetic determinants of pregnancy loss | 002 | 2 | NIH | 7/24/2025 | $159,000 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD115359 | 5-base HiFi sequencing to advance the understanding of genetic determinants of pregnancy loss | 001 | 2 | NIH | 5/15/2025 | $0 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD115359 | 5-base HiFi sequencing to advance the understanding of genetic determinants of pregnancy loss | 000 | 2 | NIH | 4/7/2025 | $671,544 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R21HD116421 | Inhaled ciclesonide - a phase I study in preterm infants | 000 | 2 | NIH | 7/23/2025 | $195,800 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD110447 | Systematic Identification and Phenotypic Characterization of causal genetic variants in Rare Disease-Associated Birth Defects | 001 | 3 | NIH | 4/17/2025 | $64,111 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD110447 | Systematic Identification and Phenotypic Characterization of causal genetic variants in Rare Disease-Associated Birth Defects | 000 | 3 | NIH | 11/22/2024 | $577,011 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R35GM146966 | Mapping causal genetic processes in non-Mendelian pediatric rare disease | 000 | 4 | NIH | 8/6/2025 | $389,220 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23MH130728 | Development of a Pharmacodynamic Biomarker of Opioid Antagonism in Adolescents with Eating Disorders | 000 | 3 | NIH | 4/11/2025 | $183,980 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R21DE033120 | Development of a Novel Diagnostic Modality for Upper Airway Obstruction via Integrating Dynamic Computed Tomography with Computational Fluid Dynamics | 000 | 2 | NIH | 7/31/2025 | $216,994 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01CA285616 | Simultaneous ROS production and DDR inhibition to trigger p53 synthetic lethality | 000 | 1 | NIH | 3/11/2025 | $560,458 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23HL159325 | Remotely Delivered Cardiac Rehabilitation for Adolescents with Congenital Heart Disease | 000 | 4 | NIH | 5/23/2025 | $144,632 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R35GM156410 | An integrative approach to identify biomarkers and investigate mechanisms of adverse drug reactions | 000 | 1 | NIH | 5/2/2025 | $433,669 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23HL173648 | Systemic Corticosteroid Pharmacokinetics and Pharmacodynamic Biomarker Identification in Children with Asthma and Obesity | 000 | 1 | NIH | 4/25/2025 | $188,073 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 03 | 8 | HRSA | 7/30/2025 | $281,743 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 03 | 8 | HRSA | 7/30/2025 | $610,739 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 02 | 8 | HRSA | 6/13/2025 | $390,806 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 02 | 8 | HRSA | 6/13/2025 | $847,154 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 8 | HRSA | 4/11/2025 | $363,541 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 8 | HRSA | 4/11/2025 | $788,051 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $363,541 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $788,051 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T32HD069038 | Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology | 000 | 15 | NIH | 4/23/2025 | $298,713 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T32HD069038 | Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology | 001 | 15 | NIH | 6/3/2025 | $4,428 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23HD114899 | Pharmacogenomic Contribution to the Biotransformation of Trihexyphenidyl and Development of a Precision Dosing Model for Children with Dystonia and Cerebral Palsy | 000 | 1 | NIH | 1/20/2025 | $164,160 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01DK139636 | SIGIRR in the Neonatal Intestine | 000 | 1 | NIH | 12/31/2024 | $630,847 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R34MH132473 | Enhancing communication on relationship preservation, safer conception and PrEP to promote HIV testing | 000 | 3 | NIH | 12/19/2024 | $177,109 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HL162937 | DLL4 in the Developing Lung and Bronchopulmonary Dysplasia (BPD) | 001 | 3 | NIH | 7/29/2025 | $56,644 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HL162937 | DLL4 in the Developing Lung and Bronchopulmonary Dysplasia (BPD) | 000 | 3 | NIH | 3/25/2025 | $509,803 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD111570 | Unraveling the Genomic Causes for Unsolved Leukodystrophy Patients by HiFi-GS | 001 | 2 | NIH | 7/23/2025 | $505,862 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD111570 | Unraveling the Genomic Causes for Unsolved Leukodystrophy Patients by HiFi-GS | 002 | 2 | NIH | 8/7/2025 | $107,722 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 002 | 23 | NIH | 7/30/2025 | $859,674 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 004 | 23 | NIH | 8/8/2025 | $81,527 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 003 | 23 | NIH | 8/7/2025 | $43,639 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23MH133874 | Brief Mental Health Treatment For Parents of Children with Pediatric Feeding Disorder | 000 | 2 | NIH | 3/19/2025 | $164,242 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD117565 | Complete human parent-of-origin genome: functional signatures and developmental determinants of disease. | 000 | 1 | NIH | 8/14/2025 | $681,829 |
| | 2025 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01CA290670 | DNA Repair Deficiencies in Infertile Men and Cancer Risk | 001 | 2 | NIH | 2/26/2025 | $34,414 |
| | 2025 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | H9E53187 | Transition for Youth with Autism and/or Epilepsy Demonstration Projects | 03 | 1 | HRSA | 3/22/2025 | $0 |
| | 2025 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | H9E53187 | Transition for Youth with Autism and/or Epilepsy Demonstration Projects | 02 | 1 | HRSA | 12/16/2024 | $0 |
| | 2025 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23DA055736 | Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital | 000 | 3 | NIH | 3/31/2025 | $0 |
| | 2025 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23DA055736 | Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital | 002 | 3 | NIH | 5/8/2025 | -$110,576 |
|
